Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherShareholder's EquityShares OutstandingShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesNon-Current ReceivablesOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetReceivables - OtherReceivables RefundsShares OutstandingShares Outstanding
Ratios

Bioceres Crop Solutions (BIOX) Receivables - Net (2017 - 2026)

Bioceres Crop Solutions' Receivables - Net history spans 10 years, with the latest figure at $136.3 million for Q1 2026.

  • On a quarterly basis, Receivables - Net changed N/A to $136.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $136.3 million, a N/A change, with the full-year FY2025 number at $165.9 million, down 19.98% from a year prior.
  • Receivables - Net hit $136.3 million in Q1 2026 for Bioceres Crop Solutions, down from $165.9 million in the prior quarter.
  • Over the last five years, Receivables - Net for BIOX hit a ceiling of $207.3 million in Q2 2024 and a floor of $111.8 million in Q2 2022.
  • Historically, Receivables - Net has averaged $155.9 million across 5 years, with a median of $158.0 million in 2023.
  • Biggest five-year swings in Receivables - Net: soared 41.39% in 2023 and later decreased 19.98% in 2025.
  • Tracing BIOX's Receivables - Net over 5 years: stood at $111.8 million in 2022, then soared by 41.39% to $158.0 million in 2023, then soared by 31.21% to $207.3 million in 2024, then fell by 19.98% to $165.9 million in 2025, then dropped by 17.84% to $136.3 million in 2026.
  • Business Quant data shows Receivables - Net for BIOX at $136.3 million in Q1 2026, $165.9 million in Q2 2025, and $207.3 million in Q2 2024.